UBS Group
CHNG

UBS Group’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

UBS Group’s Portfolio CHNG Stock Details CHNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-366,313
Closed -$10.1M – 11999
2022
Q3 		$10.1M Sell
366,313
-1,512,694
-81% -$37.5M ﹤0.01% 1789
2022
Q2 		$43.3M Buy
1,879,007
+231,161
+14% +$5.4M 0.02% 816
2022
Q1 		$35.9M Buy
1,647,846
+1,632,717
+10,792% +$33.9M 0.01% 1045
2021
Q4 		$323K Buy
15,129
+7,080
+88% +$148K ﹤0.01% 5317
2021
Q3 		$169K Sell
8,049
-33,563
-81% -$732K ﹤0.01% 5446
2021
Q2 		$959K Buy
41,612
+2,074
+5% +$47.7K ﹤0.01% 4216
2021
Q1 		$874K Buy
39,538
+5,563
+16% +$129K ﹤0.01% 4396
2020
Q4 		$633K Buy
33,975
+26,460
+352% +$435K ﹤0.01% 4411
2020
Q3 		$109K Sell
7,515
-110,260
-94% -$1.4M ﹤0.01% 5132
2020
Q2 		$1.32M Buy
117,775
+103,784
+742% +$1.17M ﹤0.01% 3274
2020
Q1 		$140K Buy
13,991
+10,223
+271% +$143K ﹤0.01% 5010
2019
Q4 		$61K Buy
+3,768
New +$50.5K ﹤0.01% 6247

Other funds holding CHNG

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's CHNG Position: Q4 2022 in Review

UBS Group sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 366,313 shares — an estimated $10.1M sold.

UBS Group first reported a position in CHNG in Q4 2019 and held it in 12 quarters. The position peaked at $43.3M in Q2 2022. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • UBS Group reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 366,313 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $10.1M.
  • UBS Group first reported a position in Change Healthcare Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • UBS Group's Change Healthcare Inc. Common Stock position peaked at $43.3M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.